Serón D, Moreso F, Bover J, Condom E, Gil-Vernet S, Cañas C, Fulladosa X, Torras J, Carrera M, Grinyó J M, Alsina J
Department of Nephrology, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain.
Kidney Int. 1997 Jan;51(1):310-6. doi: 10.1038/ki.1997.38.
To evaluate whether biopsies performed early after transplantation in stable grafts can predict graft failure due to chronic transplant nephropathy, a protocol biopsy was performed at three months in 98 patients treated with antilymphocytic antibodies, cyclosporine and prednisone. Patients were followed for 58 +/- 16 months. Histological diagnosis according to the Banff schema were: normal (N = 41), borderline changes (N = 12), chronic transplant nephropathy (CTN; N = 30), CTN associated to borderline changes (N = 11) and acute rejection (N = 4). Biopsies displaying acute rejection were not considered for statistical analysis. Since clinical characteristics of patients displaying CTN either with or without tubulitis were not different, biopsies were grouped as presence or absence of CTN. Patients displaying CTN had an increased incidence of acute rejection before performing biopsy (24.3 vs. 3.9%, P = 0.003), a higher mean cyclosporine level until biopsy (242 +/- 74 vs. 214 +/- 59 ng/ml, P = 0.049) and a lower actuarial graft survival (80.5% vs. 94.4%, P = 0.024). We conclude that early protocol biopsies are useful to detect patients at risk of losing their graft due to chronic transplant nephropathy.
为评估稳定移植肾在移植后早期进行的活检能否预测慢性移植肾病导致的移植肾失功,对98例接受抗淋巴细胞抗体、环孢素和泼尼松治疗的患者在3个月时进行了方案活检。患者随访58±16个月。根据班夫标准的组织学诊断为:正常(N = 41)、临界改变(N = 12)、慢性移植肾病(CTN;N = 30)、与临界改变相关的CTN(N = 11)和急性排斥反应(N = 4)。显示急性排斥反应的活检标本不纳入统计分析。由于显示有或无肾小管炎的CTN患者的临床特征无差异,活检标本按有无CTN分组。显示CTN的患者在活检前急性排斥反应的发生率增加(24.3%对3.9%,P = 0.003),活检前平均环孢素水平较高(242±74对214±59 ng/ml,P = 0.049),移植肾实际生存率较低(80.5%对94.4%,P = 0.024)。我们得出结论,早期方案活检有助于检测因慢性移植肾病而有移植肾失功风险的患者。